Page last updated: 2024-10-23

aztreonam and Eosinophilia

aztreonam has been researched along with Eosinophilia in 2 studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Eosinophilia: Abnormal increase of EOSINOPHILS in the blood, tissues or organs.

Research Excerpts

ExcerptRelevanceReference
"Aztreonam was then discontinued and the patient was treated with supportive measures and steroids and his renal failure reversed over the course of 5 days."5.27Acute renal failure, skin rash, and eosinophilia associated with aztreonam. ( Pazmiño, P, 1988)
"Aztreonam was then discontinued and the patient was treated with supportive measures and steroids and his renal failure reversed over the course of 5 days."1.27Acute renal failure, skin rash, and eosinophilia associated with aztreonam. ( Pazmiño, P, 1988)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hauben, M1
Adler, C1
Pazmiño, P1

Other Studies

2 other studies available for aztreonam and Eosinophilia

ArticleYear
Acute hepatitis, interstitial nephritis, and eosinophilia.
    Annals of internal medicine, 1995, Apr-01, Volume: 122, Issue:7

    Topics: Adult; Aztreonam; Chemical and Drug Induced Liver Injury; Eosinophilia; Female; HIV Infections; Huma

1995
Acute renal failure, skin rash, and eosinophilia associated with aztreonam.
    American journal of nephrology, 1988, Volume: 8, Issue:1

    Topics: Acute Kidney Injury; Aged; Aztreonam; Combined Modality Therapy; Drug Eruptions; Eosinophilia; Human

1988